CorDx is Expected to Launch Groundbreaking 10-Minute Solution for Distinguishing COVID-19 and Flu A/B as Respiratory Cases Surge Across the U.S.
Against the backdrop of a concerning surge in respiratory diseases leading to widespread alarm across the United States, CorDx has submitted its application for its CorDx TyFast...
MedMira receives CE mark for its VYRA(TM) CoV2Flu Antigen Test
HALIFAX, NS / ACCESSWIRE / January 11, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of the CE mark for its VYRA™ CoV2Flu...